Study reveals chromosome-level changes that relate to drug resistance in melanoma

Precision therapies targeting melanoma and other cancers have improved patient survival, but tumors often stop responding to drugs, and recent studies point to changes in DNA – both inside and outside chromosomes – as a driving factor in tumor genesis as well as in treatment resistance.

Related Keywords

California ,United States ,San Diego ,Thomas Graeber ,Vineet Bafna ,Emily Henderson ,Metabolomics Center ,Graeber Lab ,Jonsson Comprehensive Cancer Center ,Comprehensive Cancer Center ,Cancer Discovery ,Kai Song ,Computer Science Department ,Comprehensive Cancer ,Cancer ,Chromosome ,Fell ,Na ,Drugs ,Revolution ,Genes ,Enetic ,Enomic ,Genomic Sequencing ,Melanoma ,Melanoma Cells ,Ncogenesis ,Research ,Ignaling Pathway ,Humor ,